Moreover, loss-of-function mutations in the SMAD4 tumor-suppressing gene encoded on chromosome 18q, which is a key mediator of TGFβ signaling, are involved in the late stages of the conventional pathway [1,5,6]. This evidence concerns the gene TGFB1 and neoplasm.